About Aisap
AISAP is a healthcare AI company that has developed an AI-powered point-of-care ultrasound (POCAD) system. This platform is designed to empower clinicians with immediate diagnostics by streamlining ultrasound workflows and providing AI-driven interpretations. Utilizing deep convolutional neural networks, AISAP’s technology analyzes ultrasound images in real-time, enabling medical professionals to make more informed clinical decisions and ultimately improve patient outcomes. The company’s solution aims to address the critical need for timely and accurate diagnoses, particularly in areas with limited access to specialists.
Currently, AISAP’s primary focus is on cardiac diagnostics, having developed AISAP CARDIO, the world’s first real-time AI-powered cardiac diagnostic platform. This technology facilitates life-saving bedside diagnostics for the immediate and highly accurate detection of structural heart diseases and heart failure. The platform has received FDA approval for its cardiac diagnostic software. Beyond cardiac care, the company is developing additional diagnostic products for other anatomical areas. AISAP’s algorithms have been trained on extensive datasets, including over 300,000 studies and 24 million video clips, and the technology has been validated by medical experts from leading institutions.
Focus Areas
Business Intelligence
| Key Investors | Harel Insurance Investments & Financial Services Ltd., Shoni Health Ventures, Tamir Pardo |
| Partnerships | Cardiology Consultants of Philadelphia (CCP), Sheba Medical Center, Mass General Brigham, Thomas Jefferson University Hospital, Mayo Clinic, Inova Fairfax Medical Campus, Crozer-Chester Medical Center, Stony Brook University Hospital, Global Alliance for Community Transformation |
| Acquisitions | None |
| Technology | Cloud-based, AI operating system for any POCUS device, deep convolutional neural networks, SaaS platform for Point-of-Care Assisted Diagnosis (POCAD™) |
| FDA Clearances | 1 cleared products (estimated) |
What Physicians Need to Know
For physicians, Aisap stands out by empowering non-cardiologists with expert-level cardiac diagnostic capabilities at the point of care, significantly increasing diagnostic confidence and accuracy. It enables faster diagnoses and reduced turnaround times through real-time AI analysis and immediate reports, leading to improved patient outcomes via earlier detection and timely interventions for critical cardiac conditions. The platform enhances workflow efficiency by automating aspects of image acquisition, interpretation, and reporting, and integrates seamlessly with existing EHR/EMR and PACS systems. This reduces the need for immediate specialist referrals, allowing frontline clinicians to manage more cases and freeing up specialists for more acute situations. The real-time quality assurance and guidance during scanning ensure reliable results, and the system's ease of use, with a short learning curve, makes advanced diagnostics accessible in diverse clinical settings, including underserved and rural areas.
Aisap's platform is designed to be vendor-agnostic and highly scalable, ensuring seamless integration with any portable ultrasound device, as well as existing Electronic Health Record (EHR), Electronic Medical Record (EMR), and Picture Archiving and Communication Systems (PACS). This allows for easy adoption into current clinical workflows without requiring significant changes to existing infrastructure.
Reviews & Opinions
Videos
News, demos, and interviews about Aisap.
Videos load interactively. If none appear, search YouTube for Aisap →
Press & Coverage
Frequently Asked Questions
Comparisons
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]